Loading
Helix BioPharma Corp. Stock: price and insider trades · Canada
Helix BioPharma Corp.: what insiders have been doing
Helix BioPharma Corp., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEDI. Over the twelve months to 18 October 2026, 12 filings were filed, from 2 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Insider buying of Helix BioPharma Corp. has been absent for the past year.
Across the 2,130 companies tracked on its exchange, the median is 12 filings; at 12 filings, this issuer sits right on that mark.
For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
12
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended July 2024 · cache
CA$0.92
Analyst consensus
Income statement
EBITDA-CA$9.2M
Net income-CA$9.3M0.0% margin
Valuation
P/Book4.8x
Beta-0.14
Balance sheet & cash
Market capCA$70.3M
Total debtCA$2.5M
Free Cash Flow-CA$5.2M
Debt / Equity2%
Profitability & ownership
ROE-50.0%
ROA-18.2%
% insiders29.0%
% institutions0.0%
Last declaration on 7 October 2026
Declarations12 total
800,000 shares@ CA$1.301.47% mcap100.0% of flowCommon SharesTSXSEDI:4788968
17,659,500 sharesWarrantsTSXSEDI:4762865
1,500,000 sharesCommon SharesTSXSEDI:4762864
925,555 sharesCommon SharesTSXSEDI:4762863
2,000,000 shares@ CA$0.75100.0% of flowCommon SharesTSXSEDI:4762862
15,693,722 sharesCommon SharesTSXSEDI:4762858
@ €620.90Convertible DebenturesTSXSEDI:4729482
Convertible DebenturesTSXSEDI:4729475
WarrantsTSXSEDI:4723724
Common SharesTSXSEDI:4723723
300,000 sharesOptionsTSXSEDI:4723692
OptionsTSXSEDI:4723691
12 of 12 declarations
About Helix BioPharma Corp.
Helix BioPharma Corp. is a biopharmaceutical company focused on developing treatments for cancer. It is listed on the Toronto Stock Exchange (XTSE).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
